Angion Biomedica Corporation

Xiaokang Zhu

Bijoy Panicker

Rama K Mishra

Dong Sung Lim

Lambertus J W M Oehlen

Dawoon Jung

James G Tarrant

Lambertus Jwm Oehlen

The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Cytochrome P450 inhibitors and uses thereof

The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial. 

Growing community of inventors

Oakland Gardens, NY, United States of America

Xiaokang Zhu